Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature Editorial Comment
| dc.creator | Oeconomou, A. | en |
| dc.creator | Madersbacher, H. | en |
| dc.creator | Kiss, G. | en |
| dc.creator | Berger, T. J. | en |
| dc.creator | Melekos, M. | en |
| dc.creator | Rehder, P. | en |
| dc.date.accessioned | 2015-11-23T10:41:39Z | |
| dc.date.available | 2015-11-23T10:41:39Z | |
| dc.date.issued | 2009 | |
| dc.identifier.issn | 0022-5347 | |
| dc.identifier.uri | http://hdl.handle.net/11615/31466 | |
| dc.source | Journal of Urology | en |
| dc.source.uri | <Go to ISI>://WOS:000266949800098 | |
| dc.subject | Urology & Nephrology | en |
| dc.title | Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature Editorial Comment | en |
| dc.type | journalArticle | en |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||